Correlation Between LIFE Old and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both LIFE Old and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LIFE Old and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LIFE Old and Inhibikase Therapeutics, you can compare the effects of market volatilities on LIFE Old and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LIFE Old with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LIFE Old and Inhibikase Therapeutics.
Diversification Opportunities for LIFE Old and Inhibikase Therapeutics
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between LIFE and Inhibikase is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding LIFE Old and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and LIFE Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LIFE Old are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of LIFE Old i.e., LIFE Old and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between LIFE Old and Inhibikase Therapeutics
If you would invest (100.00) in LIFE Old on October 25, 2024 and sell it today you would earn a total of 100.00 from holding LIFE Old or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
LIFE Old vs. Inhibikase Therapeutics
Performance |
Timeline |
LIFE Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibikase Therapeutics |
LIFE Old and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LIFE Old and Inhibikase Therapeutics
The main advantage of trading using opposite LIFE Old and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LIFE Old position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.LIFE Old vs. Mereo BioPharma Group | LIFE Old vs. Terns Pharmaceuticals | LIFE Old vs. PDS Biotechnology Corp | LIFE Old vs. Inozyme Pharma |
Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |